11 drug(s) with this reaction
9,951 total reports
Decreased Appetite has been reported as an adverse reaction across 11 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 9,951 adverse event reports mention decreased appetite in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with decreased appetite, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have decreased appetite listed in their FDA adverse event reports, sorted by report count:
In addition to decreased appetite, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
11 drug(s) manufactured by Amgen Inc have decreased appetite listed in their FDA adverse event reports: APREMILAST, DENOSUMAB, PEGFILGRASTIM, CINACALCET HYDROCHLORIDE, FILGRASTIM, and others.
There are a combined 9,951 reports of decreased appetite across 11 Amgen Inc drug(s) in the FDA adverse event database.